Abortion drug remains approved, with restrictions, appeals court rules - Eagle Pass Business Journal

Contributing sentiments towards policy:

55% : But the defendants, a group of anti-abortion doctors and medical associations, were still within the statute of limitations to challenge changes made to the drug's approval in 2016 and 2022, as well as the approval of a generic version of the medication,the court ruled.
54% : Countless studies have shown the medication to be safe and effective, with minimal adverse effects, but it has emerged as a focal point for anti-abortion advocates who see it as a workaround to state abortion bans.
54% : "The effect of the district court's decision, if it was allowed to take effect, is to essentially put FDA approval on ice," said Pincus.
53% :Kacsmaryk's ruling, which relied heavily on anti-abortion language and studies, has confounded legal, medical and FDA experts.
46% : "If Judge Kacsmaryk gets away with his attempt to undo the approval of mifepristone for the entire nation, the effect will be felt in all 50 states, even where abortion is legal and protected."
39% :"This Texas case was brought as the next step to ban abortion nationwide," said Jennifer Dalven, director of the American Civil Liberties Union's Reproductive Freedom Project.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.